Patriot Financial Group Insurance Agency’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,700
Closed -$96K 1801
2022
Q2
$96K Sell
12,700
-16,750
-57% -$146K 0.02% 560
2022
Q1
$277K Buy
29,450
+17,980
+157% +$150K 0.05% 344
2021
Q4
$92K Buy
11,470
+5,227
+84% +$47.2K 0.02% 673
2021
Q3
$61K Buy
6,243
+2,143
+52% +$20.1K 0.01% 805
2021
Q2
$41K Buy
4,100
+2,716
+196% +$28.7K 0.01% 906
2021
Q1
$16K Buy
1,384
+917
+196% +$10.5K ﹤0.01% 1199
2020
Q4
$5K Buy
+467
New +$4.47K ﹤0.01% 1448
2019
Q4
Sell
-101
Closed -$1K 1445
2019
Q3
$1K Hold
101
﹤0.01% 1237
2019
Q2
$1K Hold
101
﹤0.01% 1339
2019
Q1
$2K Hold
101
﹤0.01% 1046
2018
Q4
$2K Hold
101
﹤0.01% 851
2018
Q3
$2K Buy
+101
New +$2.35K ﹤0.01% 871
2018
Q2
Sell
-163
Closed -$3K 895
2018
Q1
$3K Sell
163
-1
-0.6% -$20 ﹤0.01% 843
2017
Q4
$3K Buy
164
+1
+0.6% +$15 ﹤0.01% 839
2017
Q3
$3K Sell
163
-101
-38% -$2.27K ﹤0.01% 803
2017
Q2
$8K Buy
264
+3
+1% +$93 0.01% 586
2017
Q1
$8K Buy
261
+1
+0.4% +$34 0.01% 536
2016
Q4
$9K Buy
+260
New +$10.4K 0.01% 489

Other funds holding TEVA

Patriot Financial Group Insurance Agency's TEVA Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 12,700 shares — an estimated $96K sold.

Patriot Financial Group Insurance Agency first reported a position in TEVA in Q4 2016 and held it in 18 quarters. The position peaked at $277K in Q1 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 12,700 Teva Pharmaceuticals shares in Q3 2022, an estimated $96K.
  • Patriot Financial Group Insurance Agency first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • Patriot Financial Group Insurance Agency's Teva Pharmaceuticals position peaked at $277K in Q1 2022.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.